Other Clinical Trial - Effects of Compassion Training to Patients

Status Completed

Clinical Trial Summary

The hematopoietic stem cell transplant (HSCT) experience is emotionally and physically stressful for cancer patients who undergo this procedure. This study aims to evaluate the effects of Cognitively-Based Compassion Training (CBCT) on depression and anxiety symptoms, levels of resilience, hope and self-compassion in patients undergoing HSCT and their caregivers. As well as assessing the effects of CBCT on clinical conditions in patients and cortical activity and heart rate variability in caregivers.

Clinical Trial Description

The study hopes to show the positive effects of compassion training in patients and their caregivers.

Overall aim:

This study aims to evaluate the effects of Cognitively-Based Compassion Training (CBCT) on: depression and anxiety symptoms; levels of hope; resilience; mindfulness; self-compassion and quality of life. The study also aims to demonstrate whether CBCT training has any effect on clinical parameters of transplanted patients, as well as whether it has an effect on cortical activity and heart rate variability inpatients and caregivers.

Specific objectives:

1. Develop an adaptation of the CBCT protocol for hospitalized patients;

2. To evaluate the effect of CBCT on depressive and anxious symptoms in patients and their caregivers;

3. To evaluate the effect of CBCT on resilience, quality of life and self-compassion in patients and their caregivers;

4. Investigating the CBCT training results in altering the cortical activity of patients and caregivers while performing a recall task of recent autobiographical experiences;

5. Investigate whether CBCT training results in changes in heart rate variability in patients and caregivers;

6. To investigate whether CBCT training has any effect on patient's levels of symptoms, such as: pain, nausea, insomnia, among others;

7. To evaluate how correlations between psychosocial factors and biological markers: cortical activity and heart rate variability;

8. Evaluate perceptions and impressions of patients and caregivers on the protocol. ;

Study Design

Related Conditions & MeSH terms

Hematopoietic Stem Cell Transplant

Clinical Trial Details

NCT number	NCT03737084
Study type	Interventional
Source	Hospital Israelita Albert Einstein
Contact
Status	Completed
Phase	N/A
Start date	April 3, 2018
Completion date	July 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02451462` - Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients	N/A
Terminated	`NCT01215981` - Influenza Vaccine Post Allogeneic Transplant	N/A
Recruiting	`NCT03613532` - Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN	Phase 1
Completed	`NCT01337648` - Radiation Biodosimetry in Children Undergoing Total Body Irradiation	N/A
Recruiting	`NCT03250546` - Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant	Phase 2
Recruiting	`NCT02982902` - T Cell Therapy of Opportunistic Cytomegalovirus Infection	Early Phase 1
Completed	`NCT02441075` - 70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014	N/A
Completed	`NCT04549038` - Time Restricted Nutrition in Pediatric Stem Cell Transplant Recipients	N/A
Completed	`NCT03886909` - Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant	N/A
Not yet recruiting	`NCT06328127` - Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors	N/A
Completed	`NCT03509051` - Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation	N/A
Terminated	`NCT02350777` - T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation	Phase 2
Completed	`NCT04853277` - Patient Reported Outcomes and Patient Education in Cellular Therapy Patients	N/A
Completed	`NCT03378089` - Music Therapy and Hematopoietic Stem Cell Transplant	N/A
Completed	`NCT03039257` - Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates	N/A
Completed	`NCT03202849` - A Randomized Trial of Vitamin D Supplementation With or Without Vitamin A in Stem Cell Transplantation	N/A
Completed	`NCT01581164` - Studies of the Immune Response to Vaccination After Hematopoietic Stem Cell Transplantation	N/A
Completed	`NCT01504152` - International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center	N/A
Completed	`NCT03759262` - Ultra-high Dose Vitamin D for HSCT	N/A
Recruiting	`NCT04263597` - Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Compassion Training to Patients Undergoing HSCT on Biological and Psychosocial Parameters

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms